Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

A Multicenter, Open-Label Study to Evaluate the Safe and Effective Use of an Electro-Mechanical Injection Device (E-Device) for the Subcutaneous Self-Injection of Certolizumab Pegol Solution by Subjects With Moderate to Severe Active Rheumatoid Arthritis, Active Ankylosing Spondylitis, Active Psoriatic Arthritis, or Moderately to Severely Active Crohn's Disease

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT03357471
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:37:32.064045+00:00
Published At
2019-10-25T00:00:00+00:00
Record Updated At
2019-10-25
Results Posted At
2019-10-25
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Moderate and Severe Active Rheumatoid Arthritis", "Active Psoriatic Arthritis", "Active Ankylosing Spondylitis", "Moderately to Severely Active Crohn\u0027s Disease"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2019-10-25"
protocolSection.identificationModule.nctId
"NCT03357471"
protocolSection.identificationModule.officialTitle
"A Multicenter, Open-Label Study to Evaluate the Safe and Effective Use of an Electro-Mechanical Injection Device (E-Device) for the Subcutaneous Self-Injection of Certolizumab Pegol Solution by Subjects With Moderate to Severe Active Rheumatoid Arthritis, Active Ankylosing Spondylitis, Active Psoriatic Arthritis, or Moderately to Severely Active Crohn\u0027s Disease"
protocolSection.statusModule.overallStatus
"COMPLETED"
protocolSection.designModule.phases
["PHASE3"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
"2019-10-25"

Study condition terms

  • Moderate and Severe Active Rheumatoid Arthritis (protocolSection.conditionsModule.conditions)
  • Active Psoriatic Arthritis (protocolSection.conditionsModule.conditions)
  • Active Ankylosing Spondylitis (protocolSection.conditionsModule.conditions)
  • Moderately to Severely Active Crohn's Disease (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.